Company / Shareholders' Equity
BioAge Labs, Inc. Shareholders' Equity History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$272.1M
FY2025
5-year range
-$173.4M / $323.1M
FY2023-FY2025
Trend
-15.8%
vs FY2024
Sector context
#141 of 213
Health Care
What the data says
At $272M, BioAge Labs, Inc.'s shareholders' equity ranks #141 of 213 in the Health Care sector. Improved from -$173M to $272M over the past 2 years.
Based on SEC 10-K filings.
$272M in FY2025.
Improved from -$173M to $272M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#141 of 213 in Health CareTop 66% of 213This company $272.1M Sector average $2.5B
▼
-89.3% below sector average
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 15.8% year-over-year.
- Ranks #141 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $272.1M | -15.8% |
| FY2024 | $323.1M | +286.4% |
| FY2023 | -$173.4M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026